HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EU Ushers In New Cosmetics Regs; Experts Offer Perspective

This article was originally published in The Rose Sheet

Executive Summary

The EU’s new cosmetics regulation focuses on ensuring product safety and brings blanket regulatory uniformity to member states. It also could give rise to conflicts of interest within the supply chain and other challenges, experts say.

You may also be interested in...

Liability Issues Could Arise Under Personal Care Products Safety Act

The draft Personal Care Products Safety Act’s safety substantiation requirements – including statements from responsible persons attesting to product safety – are hazily defined and could pose liability risks, in addition to burdens for small companies in particular, EAS consultant John Bailey says. For these reasons and others, the former FDAer is skeptical that industry will support the bill in its current form.

Permissible Preservatives Cited As No. 1 Industry Challenge Under EU Reg

In a survey conducted by IQPC division Pharma IQ, 31% of cosmetics industry members identified “what preservatives you can use” as the biggest challenge facing their business since implementation of the European Union’s Cosmetics Regulation in July 2013. Others cited challenges related to animal-testing alternatives and the regulation’s definition of nanomaterials.

Top Stories Of 2013: Retailers, Firms Self-Regulate As Consumer Power Grows

“The Rose Sheet” offers an overview of the year in cosmetics, analyzing 2013’s biggest news and the publication’s most-read stories. Highlights include industry efforts in the U.S. to negotiate a legislative proposal with FDA, movement among retailers to implement cosmetic safety standards and an uptick in class-action litigation targeting alleged misleading personal-care claims.

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts